Voximetry Adds Experienced Healthtech Marketing Leader to Drive Growth
MADISON, Wis.– Voximetry Incorporated, a Healthtech company with software designed to change the Standard of Care for late-stage cancer patients by creating personalized treatment plans, has announced the appointment of Lynn Bender as Vice President of Marketing. Lynn has a strong track record of Healthtech marketing leadership experience in radiology-based businesses. Her three decades of […]
Voximetry Selected As Preferred Provider of Advanced RPT Dose Assessment Services for Atherion Bioresearch CRO
Accurate dosimetry estimates allow for efficient escalation schemes in Phase I clinical trials and may improve outcomes with dosimetry-guided patient-specific dosing strategies. MADISON, Wis.— Voximetry has been selected by Atherion Bioresearch, a full-service Clinical Research Organization (CRO) company, as the preferred provider of dosimetry services. Voximetry is a commercial stage medical software and services company […]
Voximetry Announces $5M Pre-A Financing to Advance Dosimetry Imaging Biomarker
Proceeds to support advancement of extremely accurate and precise biomarker for improved management of theranostic treatments. MADISON, Wis.—Voximetry is an early commercial stage medical software and services company with unique technology to enable personalized Radiopharmaceutical Therapy (RPT) treatments for prostate and other cancer patients. The round was company led, with participation from Wisconsin Alumni Research Foundation […]
Voximetry Accelerates AI Technology Development with Strategic Technology Transfer Agreement
Voximetry, Inc and Theravision, AB aim to speed the deployment of AI-based training models in Radiopharmaceutical Therapy (RPT) dosimetry to reach patients faster. MADISON, Wis.— Voximetry is a commercial stage medical software and services company with proprietary advanced dosimetry technology and an experienced team dedicated to supporting the clinical use and development of personalized Radiopharmaceutical […]
Voximetry Accelerates Global Footprint with Key Regulatory Leadership New Hire
MADISON, Wis.– Voximetry Incorporated, a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Jill Kaeder as Vice President of Regulatory Affairs and Quality Assurance. Jill has worked in Medical Device regulated environments for […]
Voximetry Awarded $4 Million Grant from National Cancer Institute to Automate Advanced Radiopharmaceutical Therapy Dosimetry Software
MADISON, Wis.—Voximetry is a commercial stage medical software and services company with advanced technology to enable personalized Radiopharmaceutical Therapy (RPT) treatments for prostate and other cancer patients. The company has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary software for […]
Voximetry Launches Clinical Operations Support to accelerate adoption of Torch® Dose Assessment and Dosimetry Services
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Patrick Morse, MBA, as Vice President of Global Clinical Operations. Patrick has over 12 years of leadership experience in industry […]
Voximetry Announces Experienced Commercial Leadership Hired for Launch of Torch® Dose Assessment in the U.S.
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Michael Lafont, M.MSc., DABR as Vice President of Sales. Mr. Lafont has over 25 years of clinical and commercial leadership […]
Voximetry positions for growth with hiring of Chief Operating Officer Dr. Abhi Chakrabarti
MADISON, Wis.– Voximetry Inc., a Healthtech company with software designed to change the Standard of Care for late-stage prostate cancer patients by creating personalized treatment plans tailored for the individual, has announced the appointment of Dr. Abhimanyu Chakrabarti as Chief Operating Officer. Dr. Chakrabarti has over 25 years of global development and commercial leadership experience […]
Pluvicto Demonstrates Clinical Benefit in Prostate Cancer Before Chemo
Pluvicto becomes the first PSMA-targeted radioligand therapy to demonstrate clinical benefit in mCRPC patients BEFORE receiving taxane-based chemotherapy, addressing a significant unmet need Today, Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM , a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, met its primary endpoint. This study is the first PSMA-targeted radioligand therapy to demonstrate […]